These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18394725)

  • 1. Structure and sequence motifs of siRNA linked with in vitro down-regulation of morbillivirus gene expression.
    de Almeida RS; Keita D; Libeau G; Albina E
    Antiviral Res; 2008 Jul; 79(1):37-48. PubMed ID: 18394725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and mapping of a region on the mRNA of Morbillivirus nucleoprotein susceptible to RNA interference.
    Keita D; Servan de Almeida R; Libeau G; Albina E
    Antiviral Res; 2008 Nov; 80(2):158-67. PubMed ID: 18634829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An algorithm for selection of functional siRNA sequences.
    Amarzguioui M; Prydz H
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1050-8. PubMed ID: 15044091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality.
    Elmén J; Thonberg H; Ljungberg K; Frieden M; Westergaard M; Xu Y; Wahren B; Liang Z; Ørum H; Koch T; Wahlestedt C
    Nucleic Acids Res; 2005; 33(1):439-47. PubMed ID: 15653644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RFRCDB-siRNA: improved design of siRNAs by random forest regression model coupled with database searching.
    Jiang P; Wu H; Da Y; Sang F; Wei J; Sun X; Lu Z
    Comput Methods Programs Biomed; 2007 Sep; 87(3):230-8. PubMed ID: 17644215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structure-activity relationship study of siRNAs with structural variations.
    Chang CI; Hong SW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2007 Aug; 359(4):997-1003. PubMed ID: 17577577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
    Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
    Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA.
    Zhe R; Mei-Ying Z; Kitazato K; Kobayash N; Qin-Chang Z; Pei-Zhuo Z; Zhi-Rong Y; Yi-Fei W
    Arch Virol; 2008; 153(7):1401-6. PubMed ID: 18551244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated siRNA design based on surveying of features associated with high RNAi effectiveness.
    Gong W; Ren Y; Xu Q; Wang Y; Lin D; Zhou H; Li T
    BMC Bioinformatics; 2006 Nov; 7():516. PubMed ID: 17129386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production.
    Li G; Li D; Xie Q; Shi Y; Jiang S; Jin Y
    J Gene Med; 2008 Sep; 10(9):1039-47. PubMed ID: 18613219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly effective inhibition of Akabane virus replication by siRNA genes.
    Levin A; Kutznetova L; Kahana R; Rubinstein-Guini M; Stram Y
    Virus Res; 2006 Sep; 120(1-2):121-7. PubMed ID: 16616390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local RNA target structure influences siRNA efficacy: a systematic global analysis.
    Overhoff M; Alken M; Far RK; Lemaitre M; Lebleu B; Sczakiel G; Robbins I
    J Mol Biol; 2005 May; 348(4):871-81. PubMed ID: 15843019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNAdb: a database of siRNA sequences.
    Chalk AM; Warfinge RE; Georgii-Hemming P; Sonnhammer EL
    Nucleic Acids Res; 2005 Jan; 33(Database issue):D131-4. PubMed ID: 15608162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting effective siRNA target sequences by using Bayes' theorem.
    Takasaki S
    Comput Biol Chem; 2009 Oct; 33(5):368-72. PubMed ID: 19682951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting effective siRNA sequences based on the self-organizing map and statistical techniques.
    Takasaki S; Kawamura Y; Konagaya A
    Comput Biol Chem; 2006 Jun; 30(3):169-78. PubMed ID: 16600687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of siRNA target sequences by using fragmentized DNA.
    Kasim V; Taira K; Miyagishi M
    J Gene Med; 2006 Jun; 8(6):782-91. PubMed ID: 16532512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics.
    Groseth A; Hoenen T; Alimonti JB; Zielecki F; Ebihara H; Theriault S; Ströher U; Becker S; Feldmann H
    J Infect Dis; 2007 Nov; 196 Suppl 2():S382-9. PubMed ID: 17940974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel program to design siRNAs simultaneously effective to highly variable virus genomes.
    Lee HS; Ahn J; Jun EJ; Yang S; Joo CH; Kim YK; Lee H
    Biochem Biophys Res Commun; 2009 Jul; 384(4):431-5. PubMed ID: 19422797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of target site accessibility on the design of effective siRNAs.
    Tafer H; Ameres SL; Obernosterer G; Gebeshuber CA; Schroeder R; Martinez J; Hofacker IL
    Nat Biotechnol; 2008 May; 26(5):578-83. PubMed ID: 18438400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantum dot-conjugated hybridization probes for preliminary screening of siRNA sequences.
    Bakalova R; Zhelev Z; Ohba H; Baba Y
    J Am Chem Soc; 2005 Aug; 127(32):11328-35. PubMed ID: 16089462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.